{"id":"https://openalex.org/W2017845680","doi":"https://doi.org/10.1097/iae.0b013e3182695ba0","title":"SYSTEMIC BETA-BLOCKERS MAY REDUCE THE NEED FOR REPEATED INTRAVITREAL INJECTIONS IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED BY BEVACIZUMAB","display_name":"SYSTEMIC BETA-BLOCKERS MAY REDUCE THE NEED FOR REPEATED INTRAVITREAL INJECTIONS IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED BY BEVACIZUMAB","publication_year":2012,"publication_date":"2012-10-25","ids":{"openalex":"https://openalex.org/W2017845680","doi":"https://doi.org/10.1097/iae.0b013e3182695ba0","mag":"2017845680","pmid":"https://pubmed.ncbi.nlm.nih.gov/23099497"},"language":"en","primary_location":{"id":"doi:10.1097/iae.0b013e3182695ba0","doi":"https://doi.org/10.1097/iae.0b013e3182695ba0","is_oa":false,"landing_page_url":"https://doi.org/10.1097/iae.0b013e3182695ba0","pdf_url":null,"source":{"id":"https://openalex.org/S19572933","display_name":"Retina","issn_l":"0275-004X","issn":["0275-004X","1539-2864"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retina","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110087194","display_name":"Javier Antonio Montero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158107","display_name":"Hospital Universitario R\u00edo Hortega","ror":"https://ror.org/05jk45963","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210158107"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Javier A. Montero","raw_affiliation_strings":["Ophthalmology Unit, Pio del Rio Hortega University Hospital, Valladolid, Spain. javmonmor@hotmail.com","Ophthalmology Unit, Pio del Rio Hortega University Hospital, Valladolid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ophthalmology Unit, Pio del Rio Hortega University Hospital, Valladolid, Spain. javmonmor@hotmail.com","institution_ids":["https://openalex.org/I4210158107"]},{"raw_affiliation_string":"Ophthalmology Unit, Pio del Rio Hortega University Hospital, Valladolid, Spain","institution_ids":["https://openalex.org/I4210158107"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073855843","display_name":"Jos\u00e9 M. Ruiz\u2010Moreno","orcid":"https://orcid.org/0000-0001-9636-0788","observed_orcids":["https://orcid.org/0000-0001-9636-0788","https://orcid.org/0000-0002-2059-0605"]},"institutions":[{"id":"https://openalex.org/I4210120725","display_name":"Miranza","ror":"https://ror.org/02jcrnk02","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210120725"]},{"id":"https://openalex.org/I79189158","display_name":"University of Castilla-La Mancha","ror":"https://ror.org/05r78ng12","country_code":"ES","type":"education","lineage":["https://openalex.org/I79189158"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jose M. Ruiz-Moreno","raw_affiliation_strings":["Ophthalmology Unit, Albacete Medical School, Castilla La Mancha University, Albacete, Spain","VISSUM, Alicante Institute of Ophthalmology, Alicante, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ophthalmology Unit, Albacete Medical School, Castilla La Mancha University, Albacete, Spain","institution_ids":["https://openalex.org/I79189158"]},{"raw_affiliation_string":"VISSUM, Alicante Institute of Ophthalmology, Alicante, Spain","institution_ids":["https://openalex.org/I4210120725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109997571","display_name":"Maria Eugenia Sanchis\u2010Merino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158107","display_name":"Hospital Universitario R\u00edo Hortega","ror":"https://ror.org/05jk45963","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210158107"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Eugenia Sanchis-Merino","raw_affiliation_strings":["Allergy Unit, Pio del Rio Hortega University Hospital, Valladolid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergy Unit, Pio del Rio Hortega University Hospital, Valladolid, Spain","institution_ids":["https://openalex.org/I4210158107"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041856714","display_name":"Santiago P\u00e9rez-Mart\u00edn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158107","display_name":"Hospital Universitario R\u00edo Hortega","ror":"https://ror.org/05jk45963","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210158107"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Santiago Perez-Martin","raw_affiliation_strings":["Ophthalmology Unit, Pio del Rio Hortega University Hospital, Valladolid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ophthalmology Unit, Pio del Rio Hortega University Hospital, Valladolid, Spain","institution_ids":["https://openalex.org/I4210158107"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5041856714","https://openalex.org/A5110087194"],"corresponding_institution_ids":["https://openalex.org/I4210158107"],"apc_list":null,"apc_paid":null,"fwci":3.6956,"has_fulltext":false,"cited_by_count":41,"citation_normalized_percentile":{"value":0.92251911,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":90,"max":99},"biblio":{"volume":"33","issue":"3","first_page":"508","last_page":"512"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.8109999895095825},{"id":"https://openalex.org/keywords/systemic-treatment","display_name":"systemic therapy","score":0.5889999866485596},{"id":"https://openalex.org/keywords/intravitreal-bevacizumab","display_name":"intravitreal bevacizumab","score":0.8859999775886536},{"id":"https://openalex.org/keywords/choroidal-neovascularization","display_name":"choroidal neovascularization","score":0.902999997138977},{"id":"https://openalex.org/keywords/neovascular-age-related-macular-degeneration","display_name":"neovascular age-related macular degeneration","score":0.9620000123977661},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.765999972820282},{"id":"https://openalex.org/keywords/visual-acuity-outcomes","display_name":"visual acuity outcomes","score":0.6600000262260437},{"id":"https://openalex.org/keywords/central-foveal-thickness","display_name":"central foveal thickness","score":0.9710000157356262},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.5559999942779541},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.4749999940395355},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.8500000238418579},{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.7580000162124634},{"id":"https://openalex.org/keywords/diuretics","display_name":"diuretics","score":0.8100000023841858}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.912452220916748},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.672045886516571},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.6672567129135132},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.661350667476654},{"id":"https://openalex.org/C2776403814","wikidata":"https://www.wikidata.org/wiki/Q27429789","display_name":"Macular degeneration","level":2,"score":0.6546421051025391},{"id":"https://openalex.org/C2781359195","wikidata":"https://www.wikidata.org/wiki/Q5105209","display_name":"Choroidal neovascularization","level":3,"score":0.6176329255104065},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.5839306116104126},{"id":"https://openalex.org/C2779829184","wikidata":"https://www.wikidata.org/wiki/Q631361","display_name":"Diabetic retinopathy","level":3,"score":0.4648662209510803},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.27897483110427856},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.1350986361503601},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.10970479249954224},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.07581236958503723}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004232","descriptor_name":"Diuretics","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005451","descriptor_name":"Fluorescein Angiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014792","descriptor_name":"Visual Acuity","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D019233","descriptor_name":"Retreatment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D041623","descriptor_name":"Tomography, Optical Coherence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D057135","descriptor_name":"Wet Macular Degeneration","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D057135","descriptor_name":"Wet Macular Degeneration","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D057135","descriptor_name":"Wet Macular Degeneration","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D058449","descriptor_name":"Intravitreal Injections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/iae.0b013e3182695ba0","doi":"https://doi.org/10.1097/iae.0b013e3182695ba0","is_oa":false,"landing_page_url":"https://doi.org/10.1097/iae.0b013e3182695ba0","pdf_url":null,"source":{"id":"https://openalex.org/S19572933","display_name":"Retina","issn_l":"0275-004X","issn":["0275-004X","1539-2864"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retina","raw_type":"journal-article"},{"id":"pmid:23099497","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23099497","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retina (Philadelphia, Pa.)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W115097612","https://openalex.org/W1481978003","https://openalex.org/W1518237789","https://openalex.org/W1523082029","https://openalex.org/W1543796853","https://openalex.org/W1966126044","https://openalex.org/W1967093588","https://openalex.org/W1976197225","https://openalex.org/W1983365354","https://openalex.org/W1998952758","https://openalex.org/W2001210978","https://openalex.org/W2007026635","https://openalex.org/W2009476123","https://openalex.org/W2025993981","https://openalex.org/W2030106461","https://openalex.org/W2044953204","https://openalex.org/W2066326071","https://openalex.org/W2075634939","https://openalex.org/W2076285410","https://openalex.org/W2079849187","https://openalex.org/W2089733372","https://openalex.org/W2117863647","https://openalex.org/W2143109909","https://openalex.org/W2144409619","https://openalex.org/W2145951735","https://openalex.org/W2157204458","https://openalex.org/W2159516317","https://openalex.org/W2160726762","https://openalex.org/W2168850907","https://openalex.org/W2184486465","https://openalex.org/W2916371385"],"related_works":["https://openalex.org/W2025980212","https://openalex.org/W1991419272","https://openalex.org/W2021496037","https://openalex.org/W2055385676","https://openalex.org/W2599968008","https://openalex.org/W2014311047","https://openalex.org/W2090779239","https://openalex.org/W2003601553","https://openalex.org/W2084240362","https://openalex.org/W2410075717"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"evaluate":[2],"the":[3,299],"effect":[4,112],"of":[5,97,101,113,126,248,305],"concomitant":[6,107],"systemic":[7,106,114,135,261,292],"therapy":[8],"in":[9,76,141,197,222,307],"patients":[10,46,181,308],"with":[11,47,260,309,313],"choroidal":[12,48,310],"neovascularization":[13,49,311],"secondary":[14,50],"to":[15,25,51],"age-related":[16,52,314],"macular":[17,53,315],"degeneration":[18,54],"(AMD)":[19],"treated":[20,56],"by":[21,57,90],"intravitreal":[22,59,249,267,303],"bevacizumab":[23,62,306],"and":[24,74,105,124,175,206,215,232,241,278],"propose":[26],"a":[27,65],"mechanism":[28],"for":[29,301],"different":[30],"interindividual":[31],"response.":[32],"METHODS:":[33],"Retrospective,":[34],"nonrandomized,":[35],"single-center,":[36],"consecutive":[37],"interventional":[38],"case":[39],"series":[40],"study.":[41],"Forty-six":[42],"eyes":[43],"from":[44],"46":[45],"were":[55,72,109,138],"monthly":[58],"1.25":[60],"mg":[61],"injections":[63,98,127,250,268,304],"on":[64,116,258],"pro":[66],"re":[67],"nata":[68],"regime.":[69],"Patients'":[70],"files":[71],"revised":[73],"changes":[75],"Early":[77],"Treatment":[78],"Diabetic":[79],"Retinopathy":[80],"Study":[81],"best-corrected":[82,118,198],"visual":[83,119,199],"acuity,":[84,120],"central":[85,121,223],"foveal":[86,122,224],"thickness":[87,225],"as":[88],"determined":[89],"spectral":[91],"domain":[92],"optical":[93],"coherence":[94],"tomography,":[95],"number":[96,125,247],"performed,":[99],"occurrence":[100],"severe":[102],"adverse":[103],"effects,":[104],"medication":[108,115],"recorded.":[110],"The":[111,132,219,245],"final":[117],"thickness,":[123],"performed":[128],"was":[129,187,201,226,252,281],"evaluated.":[130],"RESULTS:":[131],"most":[133],"frequent":[134],"medications":[136],"recorded":[137],"angiotensin-converting-enzyme":[139],"inhibitors":[140,171],"19":[142],"patients,":[143],"beta-adrenergic":[144,262,293],"blocking":[145,263,294],"agents":[146,264,295],"(n":[147,153,157,163,167,172,177],"=":[148,154,158,164,168,173,178,193,204,210,230,236,255,271,276,285],"18),":[149],"nonsteroidal":[150],"antiinflammatory":[151],"drugs":[152],"17),":[155],"diuretics":[156],"16),":[159],"calcium":[160],"channel":[161],"blockers":[162],"14),":[165],"benzodiazepines":[166],"11),":[169],"proton-pump":[170],"9),":[174],"statins":[176],"8).":[179],"Thirty-two":[180],"had":[182],"arterial":[183],"hypertension.":[184],"Average":[185,195],"follow-up":[186],"25.1":[188],"months":[189,214,240],"(standard":[190],"deviation":[191],"[SD]":[192],"8.9).":[194],"gain":[196],"acuity":[200],"0.9":[202],"(SD":[203,209,229,235,254],"13.6)":[205],"-2.1":[207],"letters":[208],"15.9)":[211],"at":[212,238],"12":[213,239],"24":[216,242],"months,":[217,243],"respectively.":[218,244],"average":[220,246],"reduction":[221],"111":[227],"\u03bcm":[228,234],"54)":[231],"105":[233],"71)":[237],"required":[251,265],"6.7":[253],"3.2).":[256],"Patients":[257],"treatment":[259,296],"less":[266],"(5.2,":[269],"SD":[270,275],"2.4":[272],"vs.":[273],"7.9,":[274],"3.4)":[277],"this":[279],"difference":[280],"statistically":[282],"significant":[283],"(P":[284],"0.0068,":[286],"multiple":[287],"linear":[288],"regression).":[289],"CONCLUSION:":[290],"Concomitant":[291],"may":[297],"reduce":[298],"need":[300],"repeated":[302],"associated":[312],"degeneration.":[316]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}